AMN Healthcare Services Inc. Files 10-Q for Period Ending March 31, 2024

TL;DR

<b>AMN Healthcare Services Inc. has filed its Q1 2024 10-Q report.</b>

AI Summary

AMN HEALTHCARE SERVICES INC (AMN) filed a Quarterly Report (10-Q) with the SEC on May 10, 2024. AMN Healthcare Services Inc. filed a 10-Q report for the period ending March 31, 2024. The filing covers the first quarter of fiscal year 2024. The company's fiscal year ends on December 31st. The filing was made on May 10, 2024. The company is incorporated in Delaware.

Why It Matters

For investors and stakeholders tracking AMN HEALTHCARE SERVICES INC, this filing contains several important signals. This 10-Q filing provides investors with the latest financial performance and operational details for AMN Healthcare Services Inc. for the first quarter of 2024. Understanding the details within this report is crucial for assessing the company's current financial health, strategic direction, and potential risks moving forward.

Risk Assessment

Risk Level: low — AMN HEALTHCARE SERVICES INC shows low risk based on this filing. The filing is a standard quarterly report (10-Q) and does not contain immediate red flags or significant negative developments.

Analyst Insight

Review the detailed financial statements and management discussion within the 10-Q to understand revenue trends, profitability, and any new risks or opportunities.

Key Numbers

• 2024-03-31 — Period End Date (Quarterly report period)
• 2024-05-10 — Filing Date (Date the report was filed)
• 2023-12-31 — Previous Year End Date (End of the prior fiscal year)
• 2023-03-31 — Prior Year Q1 End Date (End of the first quarter of the previous year)

Key Players & Entities

• AMN HEALTHCARE SERVICES INC (company) — Filer name
• 2024-03-31 (date) — Period of report
• 2024-05-10 (date) — Filing date
• DE (jurisdiction) — State of incorporation
• 7363 (sic_code) — Standard Industrial Classification
• 001-16753 (filing_number) — SEC file number

FAQ

Industry Context

AMN Healthcare Services Inc. operates in the healthcare staffing and services industry, providing solutions to healthcare facilities.

Regulatory Implications

The filing is a standard 10-Q, adhering to SEC regulations for quarterly financial reporting.

What Investors Should Do

1. Analyze the revenue and net income figures for Q1 2024 compared to Q1 2023.
2. Examine any disclosed risk factors or management commentary regarding operational challenges or market conditions.
3. Review the balance sheet for changes in assets, liabilities, and equity.

Key Dates

• 2024-03-31: Quarterly Period End — Marks the end of the reporting period for the 10-Q filing.
• 2024-05-10: Filing Date — The date the 10-Q report was officially submitted to the SEC.

Year-Over-Year Comparison

This is the first 10-Q filing for the fiscal year 2024, providing the latest quarterly financial information.

Key Financial Figures

• $0.01 — ange on which registered Common Stock, $0.01 par value AMN New York Stock Exchange

Filing Documents

• amn-20240331.htm (10-Q) — 879KB
• amn-ex31x20240331x10q.htm (EX-3.1) — 33KB
• amn-ex311x20240331x10q.htm (EX-31.1) — 11KB
• amn-ex312x20240331x10q.htm (EX-31.2) — 11KB
• amn-ex321x20240331x10q.htm (EX-32.1) — 6KB
• amn-ex322x20240331x10q.htm (EX-32.2) — 6KB
• amn-20240331_g1.jpg (GRAPHIC) — 49KB
• 0001142750-24-000040.txt (&nbsp;) — 5476KB
• amn-20240331.xsd (EX-101.SCH) — 31KB
• amn-20240331_cal.xml (EX-101.CAL) — 76KB
• amn-20240331_def.xml (EX-101.DEF) — 129KB
• amn-20240331_lab.xml (EX-101.LAB) — 476KB
• amn-20240331_pre.xml (EX-101.PRE) — 334KB
• amn-20240331_htm.xml (XML) — 807KB

- FINANCIAL INFORMATION

PART I - FINANCIAL INFORMATION 1. Condensed Consolidated Financial Statements (unaudited): 1 Condensed Consolidated Balance Sheets, As of March 3 1 , 202 4 and December 31, 202 3 1 Condensed Consolidated Statements of Comprehensive Income, For the Three Months Ended March 3 1 , 202 4 and 202 3 2 Condensed Consolidated Statements of Stockholders' Equity, For the Three Months Ended March 3 1 , 202 4 and 202 3 3 Condensed Consolidated Statements of Cash Flows, For the Three Months Ended March 3 1 , 202 4 and 202 3 4 Notes to Unaudited Condensed Consolidated Financial Statements 6 2. Management's Discussion and Analysis of Financial Condition and Results of Operations 15 3. Quantitative and Qualitative Disclosures about Market Risk 22 4. Controls and Procedures 23

- OTHER INFORMATION

PART II - OTHER INFORMATION 1. Legal Proceedings 24 1A. Risk Factors 24 2. Unregistered Sales of Equity Securities and Use of Proceeds 24 3. Defaults Upon Senior Securities 24 4. Mine Safety Disclosures 24 5. Other Information 24 6. Exhibits 25

Signatures

Signatures 26 Table of Contents

- FINANCIAL INFORMATION

PART I - FINANCIAL INFORMATION

Condensed Consolidated Financial Statements

Item 1. Condensed Consolidated Financial Statements AMN HEALTHCARE SERVICES, INC. CONDENSED CONSOLIDATED BALANCE SHEETS (Unaudited and in thousands, except par value) March 31, 2024 December 31, 2023 ASSETS Current assets: Cash and cash equivalents $ 50,560 $ 32,935 Accounts receivable, net of allowances of $ 31,796 and $ 32,233 at March 31, 2024 and December 31, 2023, respectively 578,647 623,488 Accounts receivable, subcontractor 97,516 117,703 Prepaid expenses 25,281 21,889 Other current assets 38,742 45,670 Total current assets 790,746 841,685 Restricted cash, cash equivalents and investments 71,912 68,845 Fixed assets, net of accumulated depreciation of $ 304,689 and $ 285,081 at March 31, 2024 and December 31, 2023, respectively 194,537 191,385 Other assets 252,397 236,796 Goodwill 1,114,757 1,111,549 Intangible assets, net of accumulated amortization of $ 466,938 and $ 442,052 at March 31, 2024 and December 31, 2023, respectively 449,248 474,134 Total assets $ 2,873,597 $ 2,924,394 LIABILITIES AND STOCKHOLDERS' EQUITY Current liabilities: Accounts payable and accrued expenses $ 316,016 $ 343,847 Accrued compensation and benefits 280,513 278,536 Other current liabilities 27,374 33,738 Total current liabilities 623,903 656,121 Revolving credit facility 425,000 460,000 Notes payable, net of unamortized fees and premium 844,984 844,688 Deferred income taxes, net 15,472 23,350 Other long-term liabilities 110,047 108,979 Total liabilities 2,019,406 2,093,138 Commitments and contingencies Stockholders' equity: Preferred stock, $ 0.01 par value; 10,000 shares authorized; none issued and outstanding at March 31, 2024 and December 31, 2023 — — Common stock, $ 0.01 par value; 200,000 shares authorized; 50,537 issued and 37,924 outstanding at March 31, 2024 and 50,423 issued and 37,810 outstanding at December 31, 2023 505 504 Additional paid-in capital 512,065 506,543 Treasury stock, at cost; 12,613 shares at March 31, 2024 a

View Full Filing

View this 10-Q filing on SEC EDGAR